Medical Electrodes Market to Experience Major Revenue Surge in Near Future
The growth of the medical electrodes market is attributed to the
increasing incidence of neurological and cardiovascular disorders, subsequent
growth in diagnostic procedures, growing preference for home and ambulatory
healthcare, and increasing investment in R&D. Growing need for early disease
diagnosis, untapped emerging markets are expected to offer significant growth
opportunities for manufacturers in the coming years.
Cardiology Application:
Based on application, the medical electrodes market is segmented into
cardiology, neurophysiology, sleep disorders, intraoperative monitoring (IOM),
and other applications. In 2017, cardiology segment is expected to account for
the largest share and to register the highest CAGR of the market. This can be
attributed to the increasing prevalence of cardiovascular diseases (CVD),
growing geriatric population, rising cardiovascular health awareness, and technological
innovations in diagnostics tools and monitoring techniques. These factors drive
the growth in the market.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171260948
Technology Segment:
By technology, the medical electrodes market is segmented into dry electrodes,
wet electrodes, and needle electrodes. Dry electrodes are expected to register
the highest CAGR during the forecast period. Dry electrodes measure
biopotential signals without using any gel or adhesive. Also, procedures
involving the use of these electrodes do not require any skin preparation.
Various types of dry electrodes have been introduced in the market to overcome
the issues associated with wet electrodes. Moreover, this market segment is
witnessing numerous technological advancements focused on developing products
that provide high signal quality and better patient comfort. These factors are
expected to boost the demand for dry electrodes.
North
America to dominate the market followed by Europe:
In 2017, North America is
expected to account for the largest share of the medical electrodes market. The
high growth of the North American market is attributed to the factors such as
the high incidence of neurological and cardiovascular disorders, increasing
demand for technologically advanced electrodes, growing adoption of
non-invasive diagnostic electrodes and increasing awareness about the benefits
of early disease diagnosis.
In 2017, Europe is expected to hold the second
largest share of this market. Factors such as presence of a well-established
healthcare industry, significant funding for life sciences and medical
research, rising geriatric population, and increasing incidence of
neurodegenerative and cardiovascular disorders in several European countries are
expected to fuel the market growth in this region.
Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=171260948
The Medical Electrodes Market is highly competitive with the presence
of several small and big players. Some of the major players in the market
include 3M (US), Medtronic plc (Ireland), Ambu (US), Natus Medical Incorporated (US),
Rhythmlink International, LLC (US), Koninklijke Philips N.V. (Netherlands),
Cognionics, Inc. (US), CONMED Corporation (US), Leonhard Lang GmbH (acquired by
DCC plc), and Nihon Kohden Corporation (Japan). The other players in this market
include Compumedics Limited (Australia),
General Electric Company (US), g.Tec Medical Engineering GmbH (Austria), Vermed
(US), Vectracor (US), Neuro Therapeutics (US), Emotiv (US), BIONEN sas (Italy), Nikomed
(US), NeuroWave Systems Inc. (US), Wearable Sensing (US), Orbital Research Inc.
(US), NeuroSky (US), ANT Neuro (Netherlands), and SOMNOmedics GmbH (Germany).
Comments
Post a Comment